Enanta Pharmaceuticals Company
Enanta’s chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), hepatitis B virus (HBV), non-alcoholic steatohepatitis (NASH), human metapneumovirus (hMPV) and SARS-CoV-2. Learn more about our research.
Investors
Headquarters:
United States
Funding Status:
N/A
Employee Number:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
COVID
Investor Type:
N/A
Founded Date:
N/A
Industry:
Genomic and Epigenominc Instabillity